JanetShipleyThe Focus On Rhabdo Webinar Series continues on July 27th at 2PM Eastern with Dr. Janet Shipley talking about a double pronged strategy that uses two experimental cancer drugs together. The combination could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment. Dr. Shipley’s research team at The Institute of Cancer Research, London, found that combining two separate molecularly targeted therapies could stop processes driving growth in a cancer called rhabdomyosarcoma, a major cause of cancer death in children. Further lab work/pre-clinical testing will be required before progression to clinical testing.
For additional information Click Here